Er is iets misgegaan bij het laden van deze pagina.
Ons team heeft al een melding ontvangen, maar neem vooral contact op via de widget e-mailondersteuning als het probleem aanhoudt.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM EBITDA Multiple | -72,3x - -79,9x | -76,1x |
| Selected Fwd EBITDA Multiple | 72,9x - 80,6x | 76,8x |
| Fair Value | ₩50.455 - ₩54.201 | ₩52.328 |
| Upside | -46,2% - -42,2% | -44,2% |
| Benchmarks | Ticker | Full Ticker |
| Peptron, Inc. | A087010 | KOSDAQ:A087010 |
| FutureChem Co.,Ltd | A220100 | KOSDAQ:A220100 |
| Green Lifescience Co., Ltd. | A114450 | KOSDAQ:A114450 |
| Celemics, Inc. | A331920 | KOSDAQ:A331920 |
| The Technology Co.,Ltd. | A043090 | KOSDAQ:A043090 |
| LigaChem Biosciences Inc. | A141080 | KOSDAQ:A141080 |
| - | - | - |
| Select LTM EBITDA Multiple | |||||||
| Benchmark Companies | |||||||
| A087010 | A220100 | A114450 | A331920 | A043090 | A141080 | ||
| KOSDAQ:A087010 | KOSDAQ:A220100 | KOSDAQ:A114450 | KOSDAQ:A331920 | KOSDAQ:A043090 | KOSDAQ:A141080 | ||
| Historical EBITDA Growth | |||||||
| 5Y CAGR | NM- | NM- | -22.0% | NM- | NM- | NM- | |
| 3Y CAGR | NM- | NM- | NM- | NM- | NM- | NM- | |
| Latest Twelve Months | -6.5% | -20.9% | 152.9% | 77.4% | 33.9% | 79.1% | |
| Historical EBITDA Profit Margin | |||||||
| 5 Year Average Margin | -359.8% | -27.2% | -1.9% | -48.6% | -86.5% | -104.1% | |
| Prior Fiscal Year | -388.7% | -19.7% | -9.7% | -74.7% | -104.4% | -223.0% | |
| Latest Fiscal Year | -439.0% | -19.2% | 4.6% | -16.5% | -113.0% | -12.6% | |
| Latest Twelve Months | -439.0% | -19.2% | 4.6% | -16.5% | -72.0% | -12.6% | |
| Current Trading Multiples | |||||||
| EV / LTM Revenue | 806.92x | 26.45x | 0.90x | 1.77x | 0.06x | 22.72x | |
| EV / LTM EBITDA | -183.8x | -137.5x | 19.6x | -10.7x | -0.1x | -179.8x | |
| EV / LTM EBIT | -153.9x | -48.3x | 59.7x | -6.3x | -0.1x | -136.8x | |
| Low | Mid | High | |||||
| Benchmark EV / LTM EBITDA | -183.8x | -10.7x | 19.6x | ||||
| Historical EV / LTM EBITDA | -179.8x | -85.0x | -22.5x | ||||
| Selected EV / LTM EBITDA | -72.3x | -76.1x | -79.9x | ||||
| (x) LTM EBITDA | (15,905) | (15,905) | (15,905) | ||||
| (=) Implied Enterprise Value | 1,149,496 | 1,209,995 | 1,270,495 | ||||
| (-) Non-shareholder Claims * | 539,257 | 539,257 | 539,257 | ||||
| (=) Equity Value | 1,688,753 | 1,749,253 | 1,809,753 | ||||
| (/) Shares Outstanding | 36.3 | 36.3 | 36.3 | ||||
| Implied Value Range | 46,545.18 | 48,212.67 | 49,880.15 | ||||
| FX Rate: KRW/KRW | 1.0 | 1.0 | 1.0 | Market Price | |||
| Implied Value Range (Trading Cur) | 46,545.18 | 48,212.67 | 49,880.15 | 93,700.00 | |||
| Upside / (Downside) | -50.3% | -48.5% | -46.8% | ||||
| Equity Waterfall | |||||||
| Benchmark Companies | |||||||
| (in millions) | A087010 | A220100 | A114450 | A331920 | A043090 | A141080 | |
| Enterprise Value | 2,532,023 | 457,353 | 22,487 | (3,218) | 836 | 2,860,368 | |
| (+) Cash & Short Term Investments | 123,897 | 33,497 | 12,885 | 10,066 | 4,519 | 493,947 | |
| (+) Investments & Other | 11,544 | 58 | 0 | 15,141 | 5,048 | 46,130 | |
| (-) Debt | (9,236) | (3,795) | (5,372) | (518) | (5,787) | (820) | |
| (-) Other Liabilities | 0 | (137) | 0 | (0) | 104 | 0 | |
| (-) Preferred Stock | 0 | (6,367) | 0 | 0 | 0 | 0 | |
| (-) Other | 0 | 0 | 0 | 0 | 0 | 0 | |
| Value of Common Equity | 2,658,228 | 480,608 | 30,000 | 21,472 | 4,719 | 3,399,625 | |
| (/) Shares Outstanding | 23.3 | 22.1 | 20.0 | 8.2 | 12.4 | 36.3 | |
| Implied Stock Price | 114,100.00 | 21,750.00 | 1,500.00 | 2,630.00 | 380.00 | 93,700.00 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 114,100.00 | 21,750.00 | 1,500.00 | 2,630.00 | 380.00 | 93,700.00 | |
| Trading Currency | KRW | KRW | KRW | KRW | KRW | KRW | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |